Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs

Immunology and Allergy Clinics of North America

Volumn 34, Issue 3, 2014, Pages 507-524

  Torres, Maria Jose ^a   Barrionuevo, Esther ^a   Kowalski, Marek ^b   Blanca, Miguel ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Allergic; Clinical diagnosis; Hypersensitivity; Management; Nonallergic; Nonsteroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; IBUPROFEN; IMMUNOGLOBULIN E ANTIBODY; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ALLERGIC REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; BRONCHOCONSTRICTION; CONFUSION; CONTACT DERMATITIS; CROSS REACTION; DESENSITIZATION; DRUG DOSE INCREASE; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEVER; FIXED DRUG ERUPTION; FOOD ALLERGY; GENETIC ASSOCIATION; HUMAN; MACULOPAPULAR RASH; NOSE OBSTRUCTION; NSAID EXACERBATED CUTANEOUS DISEASE; NSAID EXACERBATED RESPIRATORY DISEASE; NSAID INDUCED URTICARIA ANGIOEDEMA; PATHOPHYSIOLOGY; PHOTOSENSITIVITY; PREVALENCE; PRIORITY JOURNAL; PROVOCATION TEST; RASH; RESPIRATORY TRACT DISEASE; REVIEW; RHINORRHEA; SINGLE NSAID INDUCED DELAYED HYPERSENSITIVITY REACTION; SINGLE NSAID INDUCED URTICARIA ANGIOEDEMA OR ANAPHYLAXIS; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN DISEASE; SKIN TEST; STEVENS JOHNSON SYNDROME; STOMACH PAIN; T LYMPHOCYTE; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; CLASSIFICATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG HYPERSENSITIVITY; HUMANS;

EID: 84904053592     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2014.04.001     Document Type: Review

References (133)

1. Roberts L.J., Morrow J.D. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. The pharmacological basis of therapeutics 2001, 687-731. McGraw-Hill, New York, Drug Allergy. 10th edition. J.G. Hardman, L.L. Limbird, A. Goodman Gilman (Eds.).
2. Celik G.E., Pichler W.J., Adkinson N.F. Drug allergy. Allergy, principles and practice 2007, 1205-1226. Elsevier, Philadelphia. 7th edition. N.F. Adkinson, B.S. Brochner, W.W. Busse (Eds.).
3. Johansson S.G., Hourihane J.O., Bousquet J., et al. Arevised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001, 56:813-824.
4. Cornejo-Garcia J.A., Blanca-Lopez N., Doña I., et al. Hypersensitivity reactions to non-steroidal anti-inflammatory drugs. Curr Drug Metab 2009, 10:971-980.
5. Kowalski M.L., Makowska J.S., Blanca M., et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)-classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA. Allergy 2011, 66:818-829.
6. Kowalski M.L., Asero R., Bavbek S., et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 2013, 68:1219-1232.
7. Ayuso P., Blanca-Lopez N., Doña I., et al. Advanced phenotyping in hypersensitivity drug reactions to NSAIDs. Clin Exp Allergy 2013, 43:1097-1109.
8. Canto M.G., Andreu I., Fernandez J., et al. Selective immediate hypersensitivity reactions to NSAIDs. Curr Opin Allergy Clin Immunol 2009, 9:293-297.
9. Stevenson D.D., Sánchez-Borges M., Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001, 87:177-180.
10. Kowalski M.L., Stevenson D.D. Classification of reactions to nonsteroidal antiinflammatory drugs. Immunol Allergy Clin North Am 2013, 33:135-145.
11. Doña I., Blanca-Lopez N., Torres M.J., et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. JInvestig Allergol Clin Immunol 2012, 22:363-371.
12. Messaad D., Sahla H., Benahmed S., et al. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004, 140:1001-1006.
13. Zambonino M.A., Torres M.J., Muñoz C., et al. Drug provocation tests in the diagnosis of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in children. Pediatr Allergy Immunol 2013, 24:151-159.
14. Gomes E., Cardoso M.F., Praca F., et al. Self-reported drug allergy in a general adult Portuguese population. Clin Exp Allergy 2004, 34:1597-1601.
15. Hedman J., Kaprio J., Poussa T. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999, 28:717-722.
16. Schubert B., Grosse Perdekamp M.T., Pfeuffer P., et al. Nonsteroidal anti-inflammatory drug hypersensitivity: fable or reality?. Eur J Dermatol 2005, 15:164-167.
17. Jenkins C., Costello J., Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004, 328:434.
18. Kasper L., Sladek K., Duplaga M., et al. Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland. Allergy 2003, 58:1064-1066.
19. Bavbek S., Dursun B., Dursun E., et al. The prevalence of aspirin hypersensitivity in patients with nasal polyposis and contributing factors. Am J Rhinol Allergy 2011, 25:411-415.
20. Szczeklik A., Nizankowska E., Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000, 16:432-436.
21. Bavbek S., Yilmaz I., Celik G., et al. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey. Allergol Immunopathol 2012, 40:225-230.
22. Doña I., Blanca-Lopez N., Cornejo-García J.A., et al. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy 2011, 41:86-95.
23. Sánchez-Borges M., Capriles-Hulett A., Caballero-Fonseca F. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management. Am J Clin Dermatol 2002, 3:599-607.
24. Erbagci Z. Multiple NSAID intolerance in chronic idiopathic urticaria is correlated with delayed, pronounced and prolonged autoreactivity. JDermatol 2004, 31:376-382.
25. Van der Klauw M.M., Stricker B.H., Herings R.M., et al. Apopulation based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmacol 1993, 35:400-408.
26. Berkes E.A. Anaphylactic and anaphylactoid reactions to aspirin and other NSAIDs. Clin Rev Allergy Immunol 2003, 24:137-148.
27. Chaudhry T., Hissaria P., Wiese M., et al. Oral drug challenges in non-steroidal anti-inflammatory drug-induced urticaria, angioedema and anaphylaxis. Intern Med J 2012, 42:665-671.
28. Himly M., Jahn-Schmid B., Pittertschatscher K., et al. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. JAllergy Clin Immunol 2003, 111:882-888.
29. Gómez E., Blanca-Lopez N., Torres M.J., et al. Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin Exp Allergy 2009, 39:1217-1224.
30. Szczeklik A., Gryglewski R.J., Czerniawska-Mysik G. Relationship of inhibition of prostaglandins biosynthesis by analgesics to asthma attacks in aspirin -sensitive patients. Br Med J 1975, 1:67-69.
31. Park H.S., Kowalski M.L., Sánchez-Borges M. Hypersensitivity to aspirin and other non-steroidal antiinflammatory drugs. Middleton's allergy principles and practice 2013, 1296-1309. Elsevier, Philadelphia. N. Franklin Adkinson, B.S. Brochner, W.W. Busse (Eds.).
32. Adkinson N.F., Brochner B.S., Busse W.W., et al. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. Am J Respir Crit Care Med 2000, 161(2 Pt 1):391-398.
33. Pierzchalska M., Szabó Z., Sanak M., et al. Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma. JAllergy Clin Immunol 2003, 111:1041-1048.
34. Yamaguchi H., Higashi N., Mita H., et al. Urinary concentrations of 15-epimer of lipoxin A(4) are lower in patients with aspirin-intolerant compared with aspirin-tolerant asthma. Clin Exp Allergy 2011, 41:1711-1718.
35. Laidlaw T.M., Kidder M.S., Bhattacharyya N., et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood 2012, 119:3790-3798.
36. Pérez-Novo C.A., Kowalski M.L., Kuna P., et al. Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship. Int Arch Allergy Immunol 2004, 133:255-260.
37. Yoo H.S., Shin Y.S., Liu J.N., et al. Clinical significance of immunoglobulin E responses to staphylococcal superantigens in patients with aspirin-exacerbated respiratory disease. Int Arch Allergy Immunol 2013, 162:340-345.
38. Szszeklik A., Nizankowska E., Sanak M. Hypersensitivity to aspirin and non-steroidal antiinflmmatory drugs. Allergy, principles and practice 2007, 1227-1246. Elsevier, Philadelphia. 7th edition. N.F. Adkinson, B.S. Brochner, W.W. Busse (Eds.).
39. Mastalerz L., Setkowicz M., Sanak M., et al. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. JAllergy Clin Immunol 2004, 113:771-775.
40. Asero R. Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria. Ann Allergy Asthma Immunol 2000, 85:156-157.
41. Perez C., Sánchez-Borges M., Capriles E. Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema. JAllergy Clin Immunol 2001, 108:1060-1061.
42. Campo P., Ayuso P., Salas M., et al. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs. Allergy 2013, 68:1001-1007.
43. Mayorga C., Torres M.J., Fernandez J., et al. Cutaneous symptoms in drug allergy: what have we learnt?. Curr Opin Allergy Clin Immunol 2009, 9:431-436.
44. Pichler W.J., Yawalkar N., Britschgi M., et al. Cellular and molecular pathophysiology of cutaneous drug reactions. Am J Clin Dermatol 2002, 3:229-238.
45. Duroudier N.P., Tulah A.S., Sayers I. Leukotriene pathway genetics and pharmacogenetics in allergy. Allergy 2009, 64(6):823-839.
46. Kim S.H., Ye Y.M., Palikhe N.S., et al. Genetic and ethnic risk factors associated with drug hypersensitivity. Curr Opin Allergy Clin Immunol 2010, 10:280-290.
47. Sanak M., Pierzchalska M., Bazan-Socha S., et al. Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol 2000, 23:290-296.
48. Kawagishi Y., Mita H., Taniguchi M., et al. Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. JAllergy Clin Immunol 2002, 109:936-942.
49. Choi J.H., Park H.S., Oh H.B., et al. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet 2004, 114:337-344.
50. Kim J.M., Park B.L., Park S.M., et al. Association analysis of N-acetyl transferase-2 polymorphisms with aspirin intolerance among asthmatics. Pharmacogenomics 2010, 11:951-958.
51. Pillai S.G., Cousens D.J., Barnes A.A., Investigators of the GAIN Network, et al. Acoding polymorphism in the CYSLT2 receptor with reduced affinity to LTD4 is associated with asthma. Pharmacogenetics 2004, 14:627-633.
52. Park J.S., Chang H.S., Park C.S., et al. Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics. Pharmacogenet Genomics 2005, 15:483-492.
53. Kim S.H., Choi J.H., Park H.S., et al. Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma. Clin Exp Allergy 2005, 35:585-590.
54. Kim S.H., Kim Y.K., Park H.W., et al. Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. Pharmacogenet Genomics 2007, 17:295-304.
55. Park B.L., Park S.M., Park J.S., et al. Association of PTGER gene family polymorphisms with aspirin intolerant asthma in Korean asthmatics. BMB Rep 2010, 43:445-449.
56. Cornejo-García J.A., Jagemann L.R., Blanca-López N., et al. Genetic variants of the arachidonic acid pathway in non-steroidal anti-inflammatory drug-induced acute urticaria. Clin Exp Allergy 2012, 42:1772-1781.
57. Agúndez J.A., Ayuso P., Cornejo-García J.A., et al. The diamine oxidase gene is associated with hypersensitivity response to non-steroidal anti-inflammatory drugs. PLoS One 2012, 7:e47571.
58. Kim J.H., Park B.L., Cheong H.S., et al. Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma. PLoS One 2010, 5:e13818.
59. Park B.L., Kim T.H., Kim J.H., et al. Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population. Hum Genet 2013, 132:313-321.
60. Cornejo-García J.A., Liou L.B., Blanca-López N., et al. Genome-wide association study in NSAID-induced acute urticaria/angioedema in Spanish and Han Chinese populations. Pharmacogenomics 2013, 14:1857-1869.
61. Szczeklik A., Stevenson D.D. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. JAllergy Clin Immunol 2003, 111:913-921.
62. Bochenek G., Kuschill-Dziurda J., Szafraniec K., et al. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis. JAllergy Clin Immunol 2014, 133:98-103.
63. Pawliczak R., Lewandowska-Polak A., Kowalski M.L. Pathogenesis of nasal polyps: an update. Curr Allergy Asthma Resp 2005, 6:463-471.
64. Kowalski M.L., Ptasinska A., Bienkiewicz B., et al. Aspirin-triggered 15-HETE generation in peripheral blood leukocytes is a sensitive and specific and Aspirin Sensitive Patients Identification Test (ASPITest). Allergy 2005, 60:1139-1145.
65. Asero R., Bavbek S., Blanca M., et al. Clinical management of patients with a history of urticaria/angioedema induced by multiple NSAIDs: an expert panel review. Int Arch Allergy Immunol 2013, 160:126-133.
66. Torres M.J., Mayorga C., Blanca M. Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests. JInvestig Allergol Clin Immunol 2009, 19:80-90.
67. Brunetti L., Francavilla R., Miniello V.L., et al. High prevalence of autoimmune urticaria in children with chronic urticaria. JAllergy Clin Immunol 2004, 114:922-927.
68. Asero R. Multiple nonsteroidal anti-inflammatory drug induced cutaneous disease: what differentiates patients with and without underlying chronic spontaneous urticaria. Int Arch Allergy Immunol 2013, 163:114-118.
69. Doña I., Blanca-López N., Torres M.J., et al. NSAID-induced urticaria/angioedema does not evolve into chronic urticaria: a 12-year follow-up study. Allergy 2013, 69(4):438-444. 10.1111/all.12335.
70. Sánchez-Borges M., Suárez-Chacón R., Capriles-Hulett A., et al. An update on oral anaphylaxis from mite ingestion. Ann Allergy Asthma Immunol 2005, 94:216-220.
71. Sánchez-Borges M., Suárez-Chacón R., Capriles-Hulett A., et al. Pancake syndrome (oral mite anaphylaxis). World Allergy Organ J 2009, 2:91-96.
72. Sánchez-Borges M., Capriles-Hulett A., Capriles-Behrens E., et al. Anew triad: sensitivity to aspirin, allergic rhinitis, and severe allergic reaction to ingested aeroallergens. Cutis 1997, 59:311-314.
73. Gómez F., Doña I., Blanca-López N., et al. Food allergy is not a risk factor in cross-intolerance to nsaids for induction of symptoms. JAllergy Clin Immunol 2013, 131:167. [abstract].
74. Gala G., Blanco R., Quirce S., et al. Diclofenac-induced urticaria with aspirin tolerance. Allergy 1998, 53:623-624.
75. van Puijenbroek E.P., Egberts A.C., Meyboom R.H., et al. Different risks for NSAID-induced anaphylaxis. Ann Pharmacother 2002, 36:24-29.
76. Klote M.M., Smith L.J. Acase of anaphylaxis to naproxen. Allergy 2005, 60:260-261.
77. Scala E., Giani M., Pirrotta L., et al. Selective severe anaphylactic reaction due to ketorolac tromethamine without nonsteroidal anti-inflammatory drug intolerance. JAllergy Clin Immunol 2001, 107:557.
78. Kvedariene V., Bencherioua A.M., Messaad D., et al. The accuracy of the diagnosis of suspected paracetamol (acetaminophen) hypersensitivity: results of a single-blinded trial. Clin Exp Allergy 2002, 32:1366-1369.
79. Stricker B.H., Meyboom R.H., Lindquist M. Acute hypersensitivity reactions to paracetamol. Br Med J (Clin Res Ed) 1985, 29:938-939.
80. Leung R., Plomley R., Czarny D. Paracetamol anaphylaxis. Clin Exp Allergy 1992, 22:831-833.
81. Ownby D.R. Acetaminophen-induced urticaria and tolerance of ibuprofen in an eight-year-old child. JAllergy Clin Immunol 1997, 99(1 Pt 1):151-152.
82. Vidal C., Pérez-Carral C., González-Quintela A. Paracetamol (acetaminophen) hypersensitivity. Ann Allergy Asthma Immunol 1997, 79:320-321.
83. Quiralte J., Blanco C., Castillo R., et al. Anaphylactoid reactions due to nonsteroidal antiinflammatory drugs: clinical and cross-reactivity studies. Ann Allergy Asthma Immunol 1997, 78:293-296.
84. Schuster C., Wüthrich B. Anaphylactic drug reaction to celecoxib and sulfamethoxazole: cross reactivity or coincidence?. Allergy 2003, 58:1072.
85. Nettis E., Giordano D., Colanardi M.C., et al. Delayed-type hypersensitivity rash from ibuprofen. Allergy 2003, 58:539-540.
86. Macias E., Ruiz A., Moreno E., et al. Usefulness of intradermal test and patch test in the diagnosis of nonimmediate reactions to metamizol. Allergy 2007, 62:1462-1464.
87. Bernedo N., Audicana M.T., Uriel O., et al. Metamizol as a cause of postoperative erythroderma. Contact Dermatitis 2004, 50:317-318.
88. Sánchez-Borges M., Capriles-Hulett A., Caballero-Fonseca F. Cutaneous hypersensitivity reactions to inhibitors of cyclooxygenase-2. Results of 307 oral provocation tests and review of the literature. Allergy Clin Immunol Int-J World Allergy Org 2007, 19:44-49.
89. Cantisani C., Grieco T., Faina V., et al. Ketoprofen allergic reactions. Recent Pat Inflamm Allergy Drug Discov 2010, 4:58-64.
90. Lynde C.B., Pierscianowski T.A., Pratt M.D. Allergic contact dermatitis caused by diclofenac cream. CMAJ 2009, 181:925-926.
91. Devleeschouwer V., Roelandts R., Garmyn M., et al. Allergic and photoallergic contact dermatitis from ketoprofen: results of (photo) patch testing and follow-up of 42 patients. Contact Dermatitis 2008, 58:159-166.
92. Montoro J., Rodríguez M., Díaz M., et al. Photoallergic contact dermatitis due to diclofenac. Contact Dermatitis 2003, 48:115.
93. Lee A.Y. Fixed drug eruptions. Incidence, recognition, and avoidance. Am J Clin Dermatol 2000, 1:277-285.
94. Brahimi N., Routier E., Raison-Peyron N., et al. Athree-year-analysis of fixed drug eruptions in hospital settings in France. Eur J Dermatol 2010, 20:461-464.
95. Bellini V., Stingeni L., Lisi P. Multifocal fixed drug eruption due to celecoxib. Dermatitis 2009, 20:174-176.
96. Gonzalo-Garijo M.A., Pérez-Calderón R., De Argila D., et al. Metamizole-induced acute generalized exanthematous pustulosis. Contact Derm 2003, 49:47-48.
97. Mockenhaupt M., Viboud C., Dunant A., et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. JInvest Dermatol 2008, 128:35-44.
98. Gomez E., Blanca M., Torres M.J., et al. Immunologic evaluation of drug allergy. Allergy Asthma Immunol Res 2012, 4:251-263.
99. Quiralte J., Blanco C., Castillo R., et al. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. JAllergy Clin Immunol 1996, 98:678-685.
100. Zembowicz A., Mastalerz I., Setkowicz M., et al. Histological spectrum of cutaneous reactions to aspirin in chronic idiopathic urticaria. JCutan Pathol 2004, 31:323-329.
101. Caimmi S., Caimmi D., Bousquet P.J., et al. How can we classify NSAID hypersensitivity reactions?. Validation from a large database. Int Arch Allergy Immunol 2012, 159:306-312.
102. Sánchez-Borges M., Fernández-Caldas E., Capriles-Hulett A., et al. Mite induced inflammation: more than allergy. Allergy Rhinol (Providence) 2012, 3:e25-e29.
103. Sánchez-Borges M., Ouellet M., Percival M., et al. Inhibition of human cyclooxygenase-1 by Dermatophagoides allergenic extracts. JAllergy Clin Immunol 2005, 115:S51.
104. Barret N.A., Maekawa A., Rahman O.M., et al. Dectin-2 recognition of house dust mite triggers cysteinyl leukotriene generation by dendritic cells. JImmunol 2009, 182:1119-1128.
105. Sato M., Kuwahara Y., Matsuyama S., et al. 2-Formyl-3-hydrobenzyl formate (Rhizoglyphiny formate), a novel salicylaldehyde analog from the house dust mite Dermatophagoides pteronyssinus (Astigmata, pyroglyphidae). Biosci Biotechnol Biochem 1993, 57:1299-1301.
106. Fukunaga A., Shimizu H., Tanaka M., et al. Limited influence of aspirin intake on mast cell activation in patients with food-dependent exercise-induced anaphylaxis: comparison using skin prick and histamine release tests. Acta Derm Venereol 2012, 92:480-483.
107. Cardona V., Luengo O., Garriga T., et al. Co-factor-enhanced food allergy. Allergy 2012, 67:1316-1318.
108. Harada S., Horikawa T., Ashida M., et al. Aspirin enhances the induction of type I allergic symptoms when combined with food and exercise in patients with food-dependent exercise-induced anaphylaxis. Br J Dermatol 2001, 145:336-339.
109. Matsuo H., Morimoto K., Akaki T., et al. Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis. Clin Exp Allergy 2005, 35:461-466.
110. Vrieze A., Postma D.S., Kerstjens H., et al. Perimenstrual asthma: a syndrome without known cause or cure. JAllergy Clin Immunol 2003, 112:271-282.
111. Martinez-Moragón E., Plaz V., Serrano J., et al. Near-fatal asthma related to menstruation. JAllergy Clin Immunol 2004, 113:242-244.
112. Carmona M.J., Blanca M., Garcia A., et al. Intolerance to piroxicam in patients with adverse reactions to nonsteroidal anti-inflammatory drugs. JAllergy Clin Immunol 1992, 90:873-879.
113. de Weck A.L. Immunochemical effects of aspirin anhydride, a contaminant of commercial acetyl salicylic acid preparations. Int Arch Allergy Immunol 1971, 41:393-395.
114. Phils J.A., Perelmutter L. IgE mediated and nonmediated allergic type reactions to aspirin. Acta Allergol 1974, 29:474-476.
115. Hasan T., Jansen C.T. Photopatch test reactivity: effect of photoallergen concentration and UVA dosing. Contact Dermatitis 1996, 34:383-386.
116. Blanca M., Perez E., Garcia J.J., et al. Angioedema and IgE antibodies to aspirin: a case report. Ann Allergy 1989, 62:295-298.
117. Bluth M.H., Beleza P., Hajee F., et al. IgE-mediated hypersensitivity after ibuprofen administration. Ann Clin Lab Sci 2007, 37:362-365.
118. Harrer A., Lang R., Grims L., et al. Diclofenac hypersensitivity: antibody responses to the parent drug and relevant metabolites. PLoS One 2010, 5:e13707.
119. Celik G., Bavbeck S., Misirligicl Z., et al. Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E2 on this release from peripheral blood leucocytes in aspirin-induced asthmatic patients. Clin Exp Allergy 2001, 31:1615-1622.
120. Bavbek S., Ikincioǧullari A., Dursun A.B., et al. Upregulation of CD63 or CD203c alone or in combination is not sensitive in the diagnosis of nonsteroidal anti-inflammatory drug intolerance. Int Arch Allergy Immunol 2009, 150:261-270.
121. Korosec P., Mavsar N., Bajrovic N., et al. Basophil responsiveness and clinical picture of acetylsalicylic acid intolerance. Int Arch Allergy Immunol 2011, 155:257-262.
122. De Weck A.L., Sanz M.L., Gamboa P.M., et al. Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and invitro diagnosis. JInvestig Allergol Clin Immunol 2009, 19:355-369.
123. Lewandowska-Polak A., Jedrzejczak-Czechowicz M., Makowska J.S., et al. Lack of association between aspirin-triggered 15-hydroxyeicosatetraenoic acid release and mast cell/eosinophil activation in nasal polyps from aspirin-sensitive patients. JInvestig Allergol Clin Immunol 2011, 21:507-513.
124. Lee R.U., Stevenson D.D. Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res 2011, 3:3-10.
125. Blanca-Lopez N., Torres M.J., Doña I., et al. Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance. Clin Exp Allergy 2013, 43:85-91.
126. Doña I., Blanca-López N., Jagemann L.R., et al. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs. Allergy 2011, 66:1428-1433.
127. Szmidt M., Grzelewska-Rzymowska I., Kowalski M.L., et al. Tolerance to acetylsalicylic acid (ASA) induced in ASA-sensitive asthmatics does not depend on initial adverse reaction. Allergy 1987, 42:182-185.
128. Berges-Gimeno M.P., Simon R.A., Stevenson D.D. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. JAllergy Clin Immunol 2003, 111:180-186.
129. Lee J.Y., Simon R.A., Stevenson D.D. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. JAllergy Clin Immunol 2007, 119:157-164.
130. Comert S., Celebioglu E., Yucel T., et al. Aspirin 300 mg/day is effective for treating aspirin-exacerbated respiratory disease. Allergy 2013, 68:1443-1451.
131. Kowalski M.L., Grzelewska-Rzymowska I., Szmidt M., et al. Clinical efficacy of aspirin in "desensitised" aspirin-sensitive asthmatics. Eur J Respir Dis 1986, 69:219-225.
132. Burnett T., Katial R., Alam R. Mechanisms of aspirin desensitization. Immunol Allergy Clin North Am 2013, 33:223-236.
133. Woessner K.M., Simon R.A. Cardiovascular prophylaxis and aspirin "allergy". Immunol Allergy Clin North Am 2013, 33:263-274.